ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Piroxicam API Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-31S12732
Home | Market Reports | Business & Industrial| Business Services
Global Piroxicam API Market Research Report 2023
BUY CHAPTERS

Global Piroxicam API Market Research Report 2025

Code: QYRE-Auto-31S12732
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
SK Chemicals
Pfizer Inc
Nostrum
Viwit Pharmaceutical
Pidi Pharmaceutical
Jumpcan Pharmaceutical
Changjiang Pharmaceutical
Jiangxi Pharmaceutical
Maoxiang Pharmaceutical
XinAn Pharmaceutical
Mylan NV
TEVA

Piroxicam API Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Piroxicam API Market

Piroxicam API Market

The global market for Piroxicam API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Piroxicam API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Piroxicam API.
The Piroxicam API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Piroxicam API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Piroxicam API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Piroxicam API Market Report

Report Metric Details
Report Name Piroxicam API Market
CAGR 5%
Segment by Type
  • Purity≥ 99%
  • Purity≥ 99.5%
Segment by Application
  • Tablets
  • Capsule
  • Injection
  • Ointment
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company SK Chemicals, Pfizer, Nostrum, Mylan, Teva, Viwit Pharmaceutical, Pidi Pharmaceutical, Maoxiang Pharmaceutical, Jumpcan Pharmaceutical, Changjiang Pharmaceutical, XinAn Pharmaceutical, Jiangxi Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Piroxicam API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Piroxicam API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Piroxicam API Market report?

Ans: The main players in the Piroxicam API Market are SK Chemicals, Pfizer, Nostrum, Mylan, Teva, Viwit Pharmaceutical, Pidi Pharmaceutical, Maoxiang Pharmaceutical, Jumpcan Pharmaceutical, Changjiang Pharmaceutical, XinAn Pharmaceutical, Jiangxi Pharmaceutical

What are the Application segmentation covered in the Piroxicam API Market report?

Ans: The Applications covered in the Piroxicam API Market report are Tablets, Capsule, Injection, Ointment

What are the Type segmentation covered in the Piroxicam API Market report?

Ans: The Types covered in the Piroxicam API Market report are Purity≥ 99%, Purity≥ 99.5%

Recommended Reports

Active Pharmaceutical Ingredients

API Market Forecasts

Therapeutic Drug Markets

1 Piroxicam API Market Overview
1.1 Product Definition
1.2 Piroxicam API by Type
1.2.1 Global Piroxicam API Market Value Comparison by Type (2024 VS 2031)
1.2.2 Purity≥ 99%
1.2.3 Purity≥ 99.5%
1.3 Piroxicam API by Application
1.3.1 Global Piroxicam API Market Value by Application (2024 VS 2031)
1.3.2 Tablets
1.3.3 Capsule
1.3.4 Injection
1.3.5 Ointment
1.4 Global Piroxicam API Market Size Estimates and Forecasts
1.4.1 Global Piroxicam API Revenue 2020-2031
1.4.2 Global Piroxicam API Sales 2020-2031
1.4.3 Global Piroxicam API Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Piroxicam API Market Competition by Manufacturers
2.1 Global Piroxicam API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Piroxicam API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Piroxicam API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Piroxicam API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Piroxicam API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Piroxicam API, Product Type & Application
2.7 Global Key Manufacturers of Piroxicam API, Date of Enter into This Industry
2.8 Global Piroxicam API Market Competitive Situation and Trends
2.8.1 Global Piroxicam API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Piroxicam API Players Market Share by Revenue
2.8.3 Global Piroxicam API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Piroxicam API Market Scenario by Region
3.1 Global Piroxicam API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Piroxicam API Sales by Region: 2020-2031
3.2.1 Global Piroxicam API Sales by Region: 2020-2025
3.2.2 Global Piroxicam API Sales by Region: 2026-2031
3.3 Global Piroxicam API Revenue by Region: 2020-2031
3.3.1 Global Piroxicam API Revenue by Region: 2020-2025
3.3.2 Global Piroxicam API Revenue by Region: 2026-2031
3.4 North America Piroxicam API Market Facts & Figures by Country
3.4.1 North America Piroxicam API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Piroxicam API Sales by Country (2020-2031)
3.4.3 North America Piroxicam API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Piroxicam API Market Facts & Figures by Country
3.5.1 Europe Piroxicam API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Piroxicam API Sales by Country (2020-2031)
3.5.3 Europe Piroxicam API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Piroxicam API Market Facts & Figures by Region
3.6.1 Asia Pacific Piroxicam API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Piroxicam API Sales by Region (2020-2031)
3.6.3 Asia Pacific Piroxicam API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Piroxicam API Market Facts & Figures by Country
3.7.1 Latin America Piroxicam API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Piroxicam API Sales by Country (2020-2031)
3.7.3 Latin America Piroxicam API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Piroxicam API Market Facts & Figures by Country
3.8.1 Middle East and Africa Piroxicam API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Piroxicam API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Piroxicam API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Piroxicam API Sales by Type (2020-2031)
4.1.1 Global Piroxicam API Sales by Type (2020-2025)
4.1.2 Global Piroxicam API Sales by Type (2026-2031)
4.1.3 Global Piroxicam API Sales Market Share by Type (2020-2031)
4.2 Global Piroxicam API Revenue by Type (2020-2031)
4.2.1 Global Piroxicam API Revenue by Type (2020-2025)
4.2.2 Global Piroxicam API Revenue by Type (2026-2031)
4.2.3 Global Piroxicam API Revenue Market Share by Type (2020-2031)
4.3 Global Piroxicam API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Piroxicam API Sales by Application (2020-2031)
5.1.1 Global Piroxicam API Sales by Application (2020-2025)
5.1.2 Global Piroxicam API Sales by Application (2026-2031)
5.1.3 Global Piroxicam API Sales Market Share by Application (2020-2031)
5.2 Global Piroxicam API Revenue by Application (2020-2031)
5.2.1 Global Piroxicam API Revenue by Application (2020-2025)
5.2.2 Global Piroxicam API Revenue by Application (2026-2031)
5.2.3 Global Piroxicam API Revenue Market Share by Application (2020-2031)
5.3 Global Piroxicam API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 SK Chemicals
6.1.1 SK Chemicals Company Information
6.1.2 SK Chemicals Description and Business Overview
6.1.3 SK Chemicals Piroxicam API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 SK Chemicals Piroxicam API Product Portfolio
6.1.5 SK Chemicals Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Piroxicam API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Piroxicam API Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Nostrum
6.3.1 Nostrum Company Information
6.3.2 Nostrum Description and Business Overview
6.3.3 Nostrum Piroxicam API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nostrum Piroxicam API Product Portfolio
6.3.5 Nostrum Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Company Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Piroxicam API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Piroxicam API Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Piroxicam API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Piroxicam API Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Viwit Pharmaceutical
6.6.1 Viwit Pharmaceutical Company Information
6.6.2 Viwit Pharmaceutical Description and Business Overview
6.6.3 Viwit Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Viwit Pharmaceutical Piroxicam API Product Portfolio
6.6.5 Viwit Pharmaceutical Recent Developments/Updates
6.7 Pidi Pharmaceutical
6.7.1 Pidi Pharmaceutical Company Information
6.7.2 Pidi Pharmaceutical Description and Business Overview
6.7.3 Pidi Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pidi Pharmaceutical Piroxicam API Product Portfolio
6.7.5 Pidi Pharmaceutical Recent Developments/Updates
6.8 Maoxiang Pharmaceutical
6.8.1 Maoxiang Pharmaceutical Company Information
6.8.2 Maoxiang Pharmaceutical Description and Business Overview
6.8.3 Maoxiang Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Maoxiang Pharmaceutical Piroxicam API Product Portfolio
6.8.5 Maoxiang Pharmaceutical Recent Developments/Updates
6.9 Jumpcan Pharmaceutical
6.9.1 Jumpcan Pharmaceutical Company Information
6.9.2 Jumpcan Pharmaceutical Description and Business Overview
6.9.3 Jumpcan Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Jumpcan Pharmaceutical Piroxicam API Product Portfolio
6.9.5 Jumpcan Pharmaceutical Recent Developments/Updates
6.10 Changjiang Pharmaceutical
6.10.1 Changjiang Pharmaceutical Company Information
6.10.2 Changjiang Pharmaceutical Description and Business Overview
6.10.3 Changjiang Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Changjiang Pharmaceutical Piroxicam API Product Portfolio
6.10.5 Changjiang Pharmaceutical Recent Developments/Updates
6.11 XinAn Pharmaceutical
6.11.1 XinAn Pharmaceutical Company Information
6.11.2 XinAn Pharmaceutical Description and Business Overview
6.11.3 XinAn Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2020-2025)
6.11.4 XinAn Pharmaceutical Piroxicam API Product Portfolio
6.11.5 XinAn Pharmaceutical Recent Developments/Updates
6.12 Jiangxi Pharmaceutical
6.12.1 Jiangxi Pharmaceutical Company Information
6.12.2 Jiangxi Pharmaceutical Description and Business Overview
6.12.3 Jiangxi Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Jiangxi Pharmaceutical Piroxicam API Product Portfolio
6.12.5 Jiangxi Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Piroxicam API Industry Chain Analysis
7.2 Piroxicam API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Piroxicam API Production Mode & Process Analysis
7.4 Piroxicam API Sales and Marketing
7.4.1 Piroxicam API Sales Channels
7.4.2 Piroxicam API Distributors
7.5 Piroxicam API Customer Analysis
8 Piroxicam API Market Dynamics
8.1 Piroxicam API Industry Trends
8.2 Piroxicam API Market Drivers
8.3 Piroxicam API Market Challenges
8.4 Piroxicam API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
SK Chemicals
Pfizer Inc
Nostrum
Viwit Pharmaceutical
Pidi Pharmaceutical
Jumpcan Pharmaceutical
Changjiang Pharmaceutical
Jiangxi Pharmaceutical
Maoxiang Pharmaceutical
XinAn Pharmaceutical
Mylan NV
TEVA
List of Tables
 Table 1. Global Piroxicam API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Piroxicam API Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Piroxicam API Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Piroxicam API Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Piroxicam API Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Piroxicam API Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Piroxicam API Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Piroxicam API Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Piroxicam API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Piroxicam API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Piroxicam API, Product Type & Application
 Table 12. Global Key Manufacturers of Piroxicam API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Piroxicam API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piroxicam API as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Piroxicam API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Piroxicam API Sales by Region (2020-2025) & (K Units)
 Table 18. Global Piroxicam API Sales Market Share by Region (2020-2025)
 Table 19. Global Piroxicam API Sales by Region (2026-2031) & (K Units)
 Table 20. Global Piroxicam API Sales Market Share by Region (2026-2031)
 Table 21. Global Piroxicam API Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Piroxicam API Revenue Market Share by Region (2020-2025)
 Table 23. Global Piroxicam API Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Piroxicam API Revenue Market Share by Region (2026-2031)
 Table 25. North America Piroxicam API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Piroxicam API Sales by Country (2020-2025) & (K Units)
 Table 27. North America Piroxicam API Sales by Country (2026-2031) & (K Units)
 Table 28. North America Piroxicam API Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Piroxicam API Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Piroxicam API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Piroxicam API Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Piroxicam API Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Piroxicam API Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Piroxicam API Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Piroxicam API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Piroxicam API Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Piroxicam API Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Piroxicam API Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Piroxicam API Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Piroxicam API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Piroxicam API Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Piroxicam API Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Piroxicam API Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Piroxicam API Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Piroxicam API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Piroxicam API Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Piroxicam API Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Piroxicam API Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Piroxicam API Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Piroxicam API Sales (K Units) by Type (2020-2025)
 Table 51. Global Piroxicam API Sales (K Units) by Type (2026-2031)
 Table 52. Global Piroxicam API Sales Market Share by Type (2020-2025)
 Table 53. Global Piroxicam API Sales Market Share by Type (2026-2031)
 Table 54. Global Piroxicam API Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Piroxicam API Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Piroxicam API Revenue Market Share by Type (2020-2025)
 Table 57. Global Piroxicam API Revenue Market Share by Type (2026-2031)
 Table 58. Global Piroxicam API Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Piroxicam API Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Piroxicam API Sales (K Units) by Application (2020-2025)
 Table 61. Global Piroxicam API Sales (K Units) by Application (2026-2031)
 Table 62. Global Piroxicam API Sales Market Share by Application (2020-2025)
 Table 63. Global Piroxicam API Sales Market Share by Application (2026-2031)
 Table 64. Global Piroxicam API Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Piroxicam API Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Piroxicam API Revenue Market Share by Application (2020-2025)
 Table 67. Global Piroxicam API Revenue Market Share by Application (2026-2031)
 Table 68. Global Piroxicam API Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Piroxicam API Price (US$/Unit) by Application (2026-2031)
 Table 70. SK Chemicals Company Information
 Table 71. SK Chemicals Description and Business Overview
 Table 72. SK Chemicals Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. SK Chemicals Piroxicam API Product
 Table 74. SK Chemicals Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Piroxicam API Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Nostrum Company Information
 Table 81. Nostrum Description and Business Overview
 Table 82. Nostrum Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Nostrum Piroxicam API Product
 Table 84. Nostrum Recent Developments/Updates
 Table 85. Mylan Company Information
 Table 86. Mylan Description and Business Overview
 Table 87. Mylan Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Mylan Piroxicam API Product
 Table 89. Mylan Recent Developments/Updates
 Table 90. Teva Company Information
 Table 91. Teva Description and Business Overview
 Table 92. Teva Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Piroxicam API Product
 Table 94. Teva Recent Developments/Updates
 Table 95. Viwit Pharmaceutical Company Information
 Table 96. Viwit Pharmaceutical Description and Business Overview
 Table 97. Viwit Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Viwit Pharmaceutical Piroxicam API Product
 Table 99. Viwit Pharmaceutical Recent Developments/Updates
 Table 100. Pidi Pharmaceutical Company Information
 Table 101. Pidi Pharmaceutical Description and Business Overview
 Table 102. Pidi Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Pidi Pharmaceutical Piroxicam API Product
 Table 104. Pidi Pharmaceutical Recent Developments/Updates
 Table 105. Maoxiang Pharmaceutical Company Information
 Table 106. Maoxiang Pharmaceutical Description and Business Overview
 Table 107. Maoxiang Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Maoxiang Pharmaceutical Piroxicam API Product
 Table 109. Maoxiang Pharmaceutical Recent Developments/Updates
 Table 110. Jumpcan Pharmaceutical Company Information
 Table 111. Jumpcan Pharmaceutical Description and Business Overview
 Table 112. Jumpcan Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Jumpcan Pharmaceutical Piroxicam API Product
 Table 114. Jumpcan Pharmaceutical Recent Developments/Updates
 Table 115. Changjiang Pharmaceutical Company Information
 Table 116. Changjiang Pharmaceutical Description and Business Overview
 Table 117. Changjiang Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Changjiang Pharmaceutical Piroxicam API Product
 Table 119. Changjiang Pharmaceutical Recent Developments/Updates
 Table 120. XinAn Pharmaceutical Company Information
 Table 121. XinAn Pharmaceutical Description and Business Overview
 Table 122. XinAn Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. XinAn Pharmaceutical Piroxicam API Product
 Table 124. XinAn Pharmaceutical Recent Developments/Updates
 Table 125. Jiangxi Pharmaceutical Company Information
 Table 126. Jiangxi Pharmaceutical Description and Business Overview
 Table 127. Jiangxi Pharmaceutical Piroxicam API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Jiangxi Pharmaceutical Piroxicam API Product
 Table 129. Jiangxi Pharmaceutical Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Piroxicam API Distributors List
 Table 133. Piroxicam API Customers List
 Table 134. Piroxicam API Market Trends
 Table 135. Piroxicam API Market Drivers
 Table 136. Piroxicam API Market Challenges
 Table 137. Piroxicam API Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Piroxicam API
 Figure 2. Global Piroxicam API Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Piroxicam API Market Share by Type: 2024 & 2031
 Figure 4. Purity≥ 99% Product Picture
 Figure 5. Purity≥ 99.5% Product Picture
 Figure 6. Global Piroxicam API Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Piroxicam API Market Share by Application: 2024 & 2031
 Figure 8. Tablets
 Figure 9. Capsule
 Figure 10. Injection
 Figure 11. Ointment
 Figure 12. Global Piroxicam API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Piroxicam API Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Piroxicam API Sales (2020-2031) & (K Units)
 Figure 15. Global Piroxicam API Average Price (US$/Unit) & (2020-2031)
 Figure 16. Piroxicam API Report Years Considered
 Figure 17. Piroxicam API Sales Share by Manufacturers in 2024
 Figure 18. Global Piroxicam API Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Piroxicam API Players: Market Share by Revenue in Piroxicam API in 2024
 Figure 20. Piroxicam API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Piroxicam API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Piroxicam API Sales Market Share by Country (2020-2031)
 Figure 23. North America Piroxicam API Revenue Market Share by Country (2020-2031)
 Figure 24. United States Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Piroxicam API Sales Market Share by Country (2020-2031)
 Figure 27. Europe Piroxicam API Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Piroxicam API Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Piroxicam API Revenue Market Share by Region (2020-2031)
 Figure 35. China Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Piroxicam API Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Piroxicam API Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Piroxicam API Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Piroxicam API Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Piroxicam API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Piroxicam API by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Piroxicam API by Type (2020-2031)
 Figure 54. Global Piroxicam API Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Piroxicam API by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Piroxicam API by Application (2020-2031)
 Figure 57. Global Piroxicam API Price (US$/Unit) by Application (2020-2031)
 Figure 58. Piroxicam API Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Chemical API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Api Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Naproxen API Market Research Report 2025
Cefixime API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Epalrestat API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acetaminophen API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tenoxicam API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gatifloxacin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Fluorouracil API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ampicillin Sodium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Calcium Carbonate API Market Research Report 2025
Doxycycline API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
API Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Doxofylline API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nepafenac API Market Research Report 2025
Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global NSAIDs Market Research Report 2025
Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024
Global Non Steroidal Anti Inflammatory API Market Research Report 2025
Aprepitant API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global BPO in Public Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17F6185
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ultra-Thin Thermal Management Transfer Tape Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15E19879
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stencil Printer for Semiconductor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29C17006
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gamification in Sports Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4X18374
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions